ABIGAIL COLE: Open Payments
NPI 1144935602 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,276 in 106 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $16 · 2025 $2,276
Food & beverage: $2,276
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $767 |
| UCB, Inc. | 14 | $474 |
| Janssen Biotech, Inc. | 10 | $207 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| Radius Health, Inc. | 3 | $79 |
| Mallinckrodt Hospital Products Inc. | 3 | $74 |
| PFIZER INC. | 4 | $72 |
| Amgen Inc. | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| Octapharma USA, Inc. | 2 | $65 |
Products named: RINVOQ, Bimzelx, SKYRIZI, TREMFYA, Tymlos, ACTHAR, XELJANZ, COSENTYX.
Industry payments across AZ — which companies pay providers there.
